biosimilars-srilanka

Biosimilars suspension leads to monopoly in Sri Lanka

  • Rest of Asia
  • |
  • Analysis
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

With the suspension of the registration of 36 similar bio-therapeutic products in Sri Lanka, the country's healthcare market has become an open ground for the monopoly... Read more

dr-mike-harrington-vice-president-european-asia-pacific-operations-waters-corporation-france1111

Waters to continue investing in India

  • India
  • |
  • Influencers
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

Waters India, a fully owned subsidiary of Waters in the US, is celebrating its silver jubilee anniversary in India. Driven by a long-term commitment to the region,... Read more

vaccine-packaging

Packing smart for better reach of vaccines

  • US
  • |
  • Analysis
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

Over the past decade, the world has invested enormous resources and energy into the development of new and life-saving vaccines. Current vaccination programs save... Read more

vaccine-delivery-technologies

Vaccine delivery technologies of the future

  • India
  • |
  • Analysis
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

Respiratory syncytial virus (RSV), a disease that causes infections of the lower respiratory tract mostly in infants and children, claims lives of nearly 200,000... Read more

settlement-drug-fraud-gsk

GSK admits to fraud in the US, pays $3 bn in penalty

  • US
  • |
  • Analysis
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

Bangalore: British pharmaceutical giant GlaxoSmithKline (GSK), which was facing civil and criminal liabilities in the US for unlawful promotion of certain prescription... Read more

fdi-in-pharma

India continues to attract FDI in pharma

  • India
  • |
  • Analysis
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

Indian pharmaceutical companies continue to receive approval from the Foreign Investment Promotion Board (FIPB), a national agency of Government of India that provides... Read more

Biotech solutions for the modern world

Biotech solutions for the modern world

  • China
  • |
  • Analysis
  • |
  • By Narayan Kulkarni
  • |
  • 1 Comment

Biotechnology has helped Jiangxi Copper, China's largest producer of copper, remove tons of copper from waste water at its plant in Dexing City of Jiangxi Province.... Read more

The world is a Big Pharma market

Big Pharma continues acquisitions

  • India
  • |
  • Analysis
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

The first quarter of 2011 witnessed major deals in the global pharmaceutical space, with April proving to be a big month for M&A activity, with companies making... Read more

M&A activity slows down in APAC

M&A activity slows down in APAC

  • China
  • |
  • Analysis
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

In 2011, the number of mergers and acquisitions in the life sciences field of Asia Pacific witnessed a fall. An independent M&A intelligence service mergermarket... Read more

All eyes on China

Pharma companies set eyes on China

  • China
  • |
  • Analysis
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

China reported total of 97 deals worth $6.5 billion, the highest in Asia Pacific, according to a mergermarket report. The country was followed by Australia with... Read more

M&As in pharma

Big deals: M&As in pharma

  • US
  • |
  • Analysis
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

In 2011, the global pharmaceutical industry saw 504 mergers and acquisitions (M&A), with a total transaction value of $90 billion. Furthermore, the number of transactions... Read more

Market cap in APAC

Market cap in APAC touches $200 bn

  • Australia
  • |
  • Analysis
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

About 500 bioscience companies comprising pharmaceutical, biotechnology and medical technology companies listed on different stock exchanges in Asia Pacific (APAC)... Read more

Aricept leads Japan pharma market

Aricept leads Japan pharma market with $1.81 bn

  • Japan
  • |
  • Analysis
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

The top 10 pharmaceutical products being sold in the Japanese market, by both local and foreign players, contribute to about 10 percent of the $120 billion pharmaceutical... Read more

japan-medical-devices

Medical devices: A hot segment in Japan

  • Japan
  • |
  • Analysis
  • |
  • By Narayan Kulkarni
  • |
  • 1 Comment

The aging population in Japan is not only driving the medical care and pharmaceutical industry but also the medical devices market. Currently, the medical devices... Read more

old-age-japan

Aged society fuels growth of generics

  • Japan
  • |
  • Analysis
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

A rapidly aging population has burdened the healthcare system both in terms of funding and facilities and is of great concern for the Japanese government. To ease... Read more

Special Features

Survey Box

Chinese Bird Flu H5N7

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X